School Of Medicine Basic Sciences
-
Vanderbilt researchers identify potential drug combinations to improve breast cancer treatment
Kevin Murphy, Andrew W. Mellon Chair in the Humanities and professor of history of art and architecture, and Mary Anne Hunting, BA’80, have uncovered the histories of female architects in the American Modernism period of the U.S. in new research. Read MoreMar 26, 2025
-
Study uncovers significant differences in a dietary supplement’s key ingredient
A recent study by Paula Luis and Claus Schneider, researchers in the Vanderbilt University School of Medicine Basic Sciences Department of Pharmacology and the Vanderbilt Institute of Chemical Biology, has uncovered substantial inconsistencies in the alkaloid content of Corydalis yanhusuo dietary supplements. Read MoreMar 26, 2025
-
How do you maintain a cellular structure without a membrane? Researchers find that synapses can use liquids to create functional separations
The laboratory of Ege Kavalali, professor and chair of the Department of Pharmacology, published a new paper in Nature Communications that determined that liquid-liquid phase separation plays a key role within the nanostructure of synapses, and that its disruption affects evoked but not spontaneous neurotransmission. Read MoreMar 6, 2025
-
Vanderbilt biomedical research paves the way for ‘hypoallergen’ treatments against peanut allergies
A recent pair of papers from the Vanderbilt University labs of Benjamin Spiller, associate professor of pharmacology, and Scott Smith, associate professor of medicine, dig into how peanut allergies are provoked and providing support for the use of a potential treatment option: hypoallergens. Both papers were published in February in the Journal of Allergy and Clinical Immunology. Read MoreFeb 26, 2025
-
Vanderbilt and Northwestern labs discover new mechanisms that cause irregular heartbeat
Medicine often takes a one-size-fits-all approach, but a disorder’s root cause can vary. Vanderbilt researchers have found that, for people with long QT syndrome, a heart condition that causes an irregular heartbeat, a more tailored approach could be beneficial. The research, led by Vanderbilt University Professor of Biochemistry and Vice Dean of Basic Sciences Charles Sanders and Northwestern University Professor and Chair of Pharmacology Dr. Al George, was published in PNAS in February 2025. Read MoreFeb 26, 2025
-
School of Medicine Basic Sciences Vestigo Issue 6 launches
Vestigo is a print and online magazine published by the Vanderbilt University School of Medicine Basic Sciences. Published once a year, Vestigo provides an in-depth view of research that’s happening in our community, highlights trainee accomplishments, and celebrates the successes of our staff and faculty. Read MoreJan 27, 2025
-
Faculty members and alumni honored with Presidential Early Career Award
On Jan. 14, President Biden awarded nearly 400 scientists and engineers the Presidential Early Career Award for Scientists and Engineers, the highest honor bestowed by the U.S. government on outstanding scientists and engineers early in their careers. Among the awardees were six Vanderbilt faculty members and three alumni. Read MoreJan 23, 2025
-
Inaugural cohort of faculty fellows elevates Immersion Vanderbilt
Immersion Vanderbilt, now in its third year as a graduation requirement, consistently provides students with the opportunity to pursue a variety of in-depth experiences and independent projects. Students align their immersion projects with their interests—whether those are artistic, research-oriented, career-focused, globally aimed or community-engaged. Faculty from all 10 schools and colleges support students’ goals and ambitions within immersion, and this year, that support is enhanced by a new cohort of 10 Immersion Faculty Fellows who are supported by Undergraduate Education in the Office of the Provost. Read MoreJan 16, 2025
-
New center at Vanderbilt applies advanced technology to biological research
Vanderbilt University’s new Center for Computational Systems Biology brings computer science, engineering and biomedical researchers together with clinicians at Vanderbilt University Medical Center to accelerate discovery related to human diseases and conditions. Read MoreJan 16, 2025
-
First successful clinical trial of VU319 brings Alzheimer’s treatment one step closer
Researchers at the Warren Center for Neuroscience Drug Discovery, a clinical stage biotech within the Vanderbilt University School of Medicine Basic Sciences, have detailed the successful drug discovery of a Phase I Single Ascending Dose clinical trial of VU319, a drug for memory loss in people with Alzheimer’s disease and schizophrenia. Read MoreJan 9, 2025
-
First successful clinical trial of VU319 brings Alzheimer’s treatment one step closer
Researchers at the Warren Center for Neuroscience Drug Discovery, a clinical stage biotech within the Vanderbilt University School of Medicine Basic Sciences, have detailed the successful drug discovery of a Phase I Single Ascending Dose clinical trial of VU319, a drug for memory loss in people with Alzheimer’s disease and schizophrenia. Read MoreDec 19, 2024
-
Vanderbilt basic science alum Q&A: Sonja Fulmer
Sonja Fulmer, a graduate of Chemical and Physical Biology Program who is now the deputy director of the FDA’s Digital Health Center of Excellence, sat down with us to discuss her experience studying basic science at Vanderbilt and how it played a role in her successful career. Read MoreDec 10, 2024
-
New structure gives insight into mRNA export and cancers, and how viruses hijack the process to infect their host
Yi Ren’s most recent paper, published in eLife, describes the structure of a protein complex involved in mRNA export that sheds light on the underlying molecular mechanism of mRNA export and the role it plays during infection by herpes viruses. Read MoreNov 21, 2024
-
Drug discovery efforts continue in latest chemical chronicle from the Warren Center for Neuroscience Drug Discovery
Led by Craig W. Lindsley, Vanderbilt drug discovery experts set out to develop a backup drug candidate to improve memory loss in people with Alzheimer’s disease. Read MoreOct 31, 2024
-
John M. Jumper, DeepMind researcher and Vanderbilt alumnus, shares 2024 Nobel Prize in chemistry
John M. Jumper, BS’07, is one of three scientists awarded the Nobel Prize in chemistry by the Royal Swedish Academy of Sciences on Oct. 9. Jumper currently is a senior staff research scientist for DeepMind, a London-based company that made a huge leap forward in solving the protein folding problem using artificial intelligence. He is the third Vanderbilt alumnus to win a Nobel Prize. Read MoreOct 10, 2024
-
Erin Calipari wins Society for Neuroscience 2024 Outstanding Career and Research award
Erin Calipari, director of the Vanderbilt Center for Addiction Research and associate professor of pharmacology and molecular physiology and biophysics, has been recognized with the Society for Neuroscience’s 2024 Jacob P. Waletzky award. Read MoreOct 3, 2024
-
Vanderbilt University School of Medicine Basic Sciences adds Carterra’s LSAXT instrument to speed drug and vaccine research and advance patient care
Carterra Inc. and the Vanderbilt University School of Medicine Basic Sciences announced the addition of the Carterra LSAXT label-free interaction analysis platform to the Center for Structural Biology. Vanderbilt and Vanderbilt University Medical Center researchers will be able to discover and characterize large molecules including antibodies. Read MoreSep 26, 2024
-
Amanda Linkous advances lung cancer research with Merck Research Laboratories Scientific Engagement and Emerging Discovery Science program
Amanda Linkous, research associate professor of pharmacology, has been awarded a research grant from the Merck Research Laboratories Scientific Engagement and Emerging Discovery Science (SEEDS) program to identify therapeutic intervention points to prevent the colonization and proliferation of small cell lung cancer and non-small cell lung cancer in the lung and brain. Read MoreSep 24, 2024
-
Alan Hurtado, Ph.D. candidate in the chemical and physical biology program, named inaugural Linda Sealy Emerging Scholar Travel Award recipient
Alan Hurtado, a Chemical and Physical Biology Ph.D. candidate in the lab of Edward Levine, has been awarded the first Linda Sealy Emerging Scholar Travel Award. The award was established to enhance the STEM talent pipeline by promoting a more inclusive environment that supports trainees from diverse backgrounds. Read MoreSep 19, 2024
-
NEW FACULTY: Sharing wisdom with ‘advice to my younger self’
New faculty share advice to their younger selves we can all learn from! Read MoreSep 16, 2024